Correlation Between Tandem Diabetes and BioNTech

Can any of the company-specific risk be diversified away by investing in both Tandem Diabetes and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tandem Diabetes and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tandem Diabetes Care and BioNTech SE, you can compare the effects of market volatilities on Tandem Diabetes and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tandem Diabetes with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tandem Diabetes and BioNTech.

Diversification Opportunities for Tandem Diabetes and BioNTech

0.42

Correlation Coefficient

Tandem Diabetes  BioNTech

Very weak diversification

The 3 months correlation between Tandem and BioNTech is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Tandem Diabetes Care and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Tandem Diabetes is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tandem Diabetes Care are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Tandem Diabetes i.e., Tandem Diabetes and BioNTech go up and down completely randomly.

Pair Corralation between Tandem Diabetes and BioNTech

Given the investment horizon of 90 days Tandem Diabetes Care is expected to generate 1.14 times more return on investment than BioNTech. However, Tandem Diabetes is 1.14 times more volatile than BioNTech SE. It trades about 0.07 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.04 per unit of risk. If you would invest  3,135  in Tandem Diabetes Care on October 25, 2024 and sell it today you would earn a total of  365.00  from holding Tandem Diabetes Care or generate 11.64% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Tandem Diabetes Care  vs.  BioNTech SE

Tandem Diabetes Care

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Tandem Diabetes Care are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, Tandem Diabetes displayed solid returns over the last few months and may actually be approaching a breakup point.

BioNTech SE

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Tandem Diabetes and BioNTech

The main advantage of trading using opposite Tandem Diabetes and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tandem Diabetes position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Tandem Diabetes Care and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.